Omicron BA.2 Subvariant is More Transmissible

Omicron BA.2 subvariant seems to be more transmissible than BA.1. It also possesses immune-evasive properties that further reduce the protective effect of vaccination against infection. 

On 26 November 2021, WHO had designated B.1.1.529 variant of SARS-CoV-2 as a Variant of concern (VOC), and named Omicron.  

As on date, Omicron includes Pango lineage B.1.1.529 and descendent Pango lineages BA.1, BA.1.1, BA.2 and BA.3. The defining mutations fully overlaps with the lineage BA.1. The descendent lineage BA.2 differs from BA.1 in some of the mutations, including in the spike protein.  

BA.2 variant is increasing in many countries. In several countries, two Omicron subvariants are observed BA.1 and BA.2. 

In Denmark, BA.2 has rapidly replaced BA.1 and has become the dominant subvariant. In a recent nationwide study of Danish households, the secondary attack rate (SAR) was estimated as 29% and 39% in households infected with Omicron BA.1 and BA.2, respectively.  

BA.2 was found to be associated with an increased susceptibility of infection for unvaccinated individuals (Odds Ratio 2.19), fully vaccinated individuals (OR 2.45) and booster-vaccinated individuals (OR 2.99), compared to BA.1.  

The researchers also found an increased transmissibility from unvaccinated primary cases in BA.2 households when compared to BA.1 households. The pattern of increased transmissibility in BA.2 households was not observed for fully vaccinated and booster-vaccinated primary cases.   

In conclusion, Omicron BA.2 subvariant seems to be more transmissible than BA.1. It also possesses immune-evasive properties that further reduce the protective effect of vaccination against infection.  

***

Sources:  

  1. WHO 2022. Tracking SARS-CoV-2 variants. Available at https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ Accessed on 04 February 2022.  
  1. Lyngse FP, et al 2022. Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish Households. Preprint medRxiv. Posted January 30, 2022. DOI: https://doi.org/10.1101/2022.01.28.22270044 

***

Latest

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Newsletter

Don't miss

Dark Matter in the Centre of our Home Galaxy 

Fermi telescope made clean observation of excess γ-ray emission...

Perseverance: What is so Special About the Rover of NASA’s Mission Mars 2020

NASA’s ambitious mars mission Mars 2020 was successfully launched on 30...

Discovery of tomb of King Thutmose II 

Tomb of king Thutmose II, the last missing tomb...

The Research.fi Service to provide Information on Researchers in Finland

The Research.fi service, maintained by the Ministry of Education...

The Challenge of Safe Drinking Water: A Novel Solar Powered Home-based, Low Cost Water Purification System

Study describes a novel portable solar-steaming collection system with...

A New Antibody Approach to Fight Ovarian Cancer

A unique immunotherapy-based antibody approach has been developed which...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...